EDSA
Price
$2.45
Change
-$0.00 (-0.00%)
Updated
Sep 4, 04:25 PM (EDT)
Capitalization
16.93M
SNBIF
Price
$16.45
Change
+$2.17 (+15.20%)
Updated
Aug 6 closing price
Capitalization
1.18B
Interact to see
Advertisement

EDSA vs SNBIF

Header iconEDSA vs SNBIF Comparison
Open Charts EDSA vs SNBIFBanner chart's image
Edesa Biotech
Price$2.45
Change-$0.00 (-0.00%)
Volume$100
Capitalization16.93M
Sanbio
Price$16.45
Change+$2.17 (+15.20%)
Volume$500
Capitalization1.18B
EDSA vs SNBIF Comparison Chart in %
Loading...
EDSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDSA vs. SNBIF commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDSA is a StrongBuy and SNBIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (EDSA: $2.40 vs. SNBIF: $16.45)
Brand notoriety: EDSA and SNBIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDSA: 28% vs. SNBIF: 111%
Market capitalization -- EDSA: $16.93M vs. SNBIF: $1.18B
EDSA [@Biotechnology] is valued at $16.93M. SNBIF’s [@Biotechnology] market capitalization is $1.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDSA’s FA Score shows that 0 FA rating(s) are green whileSNBIF’s FA Score has 0 green FA rating(s).

  • EDSA’s FA Score: 0 green, 5 red.
  • SNBIF’s FA Score: 0 green, 5 red.
According to our system of comparison, SNBIF is a better buy in the long-term than EDSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDSA’s TA Score shows that 6 TA indicator(s) are bullish while SNBIF’s TA Score has 1 bullish TA indicator(s).

  • EDSA’s TA Score: 6 bullish, 3 bearish.
  • SNBIF’s TA Score: 1 bullish, 1 bearish.
According to our system of comparison, EDSA is a better buy in the short-term than SNBIF.

Price Growth

EDSA (@Biotechnology) experienced а +0.21% price change this week, while SNBIF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.28%. For the same industry, the average monthly price growth was +7.11%, and the average quarterly price growth was +29.28%.

Industries' Descriptions

@Biotechnology (+0.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNBIF($1.18B) has a higher market cap than EDSA($16.9M). SNBIF YTD gains are higher at: 253.763 vs. EDSA (43.155). EDSA has higher annual earnings (EBITDA): -5.73M vs. SNBIF (-2.99B). SNBIF has more cash in the bank: 3.96B vs. EDSA (12.4M). EDSA has less debt than SNBIF: EDSA (0) vs SNBIF (598M). EDSA (0) and SNBIF (0) have equivalent revenues.
EDSASNBIFEDSA / SNBIF
Capitalization16.9M1.18B1%
EBITDA-5.73M-2.99B0%
Gain YTD43.155253.76317%
P/E RatioN/AN/A-
Revenue00-
Total Cash12.4M3.96B0%
Total Debt0598M-
FUNDAMENTALS RATINGS
EDSA vs SNBIF: Fundamental Ratings
EDSA
SNBIF
OUTLOOK RATING
1..100
1246
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
10086
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
5434
P/E GROWTH RATING
1..100
10065
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNBIF's Valuation (96) in the null industry is in the same range as EDSA (98). This means that SNBIF’s stock grew similarly to EDSA’s over the last 12 months.

SNBIF's Profit vs Risk Rating (86) in the null industry is in the same range as EDSA (100). This means that SNBIF’s stock grew similarly to EDSA’s over the last 12 months.

SNBIF's SMR Rating (99) in the null industry is in the same range as EDSA (99). This means that SNBIF’s stock grew similarly to EDSA’s over the last 12 months.

SNBIF's Price Growth Rating (34) in the null industry is in the same range as EDSA (54). This means that SNBIF’s stock grew similarly to EDSA’s over the last 12 months.

SNBIF's P/E Growth Rating (65) in the null industry is somewhat better than the same rating for EDSA (100). This means that SNBIF’s stock grew somewhat faster than EDSA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDSASNBIF
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
29%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
14%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
14%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
8%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
EDSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTVA0.670.03
+5.16%
MetaVia Inc
GLDD11.59-0.03
-0.26%
Great Lakes Dredge & Dock Corp
MCHP63.28-0.32
-0.50%
Microchip Technology
BIOX2.82-0.07
-2.42%
Bioceres Crop Solutions Corp
TGS25.47-0.81
-3.08%
Transportadora de Gas del Sur SA

SNBIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNBIF has been loosely correlated with HRMY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SNBIF jumps, then HRMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNBIF
1D Price
Change %
SNBIF100%
N/A
HRMY - SNBIF
52%
Loosely correlated
+1.21%
QRON - SNBIF
34%
Loosely correlated
N/A
CING - SNBIF
28%
Poorly correlated
-0.80%
WXXWY - SNBIF
28%
Poorly correlated
+3.30%
EDSA - SNBIF
25%
Poorly correlated
+2.73%
More